Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer's disease 2025-07-10
  2. Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern 2019-07-07
  3. Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease 2019-05-24

Studies

6 studies carry this tag.

Date range

2011 to 2025

Top journals

  • Frontiers in neuroscience 1
  • JAMA neurology 1
  • Journal of neurovirology 1
  • Journal of the neurological sciences 1
  • Nature communications 1

6 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Nature communications 2025-07-10 Biomarkers

    Synaptic loss strongly correlates with cognitive impairment in Alzheimer's disease (AD), yet the mechanism linking its origin and pattern remain unclear.

  2. Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of neurovirology 2019-07-07 Biomarkers

    This study aimed to compare serum amyloid processing biomarkers among HIV subtype B (n = 25), HIV subtype C (n = 26), healthy HIV-negative controls (n = 18), and patients with Alzheimer's disease (AD; n = 24).

  3. Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Scientific reports 2019-05-24 TREM2 and immune genetics

    The role of innate immunity in dementia with Lewy bodies (DLB) has been little studied.

  4. The Alzheimer's Disease-Associated R47H Variant of TREM2 Has an Altered Glycosylation Pattern and Protein Stability

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Frontiers in neuroscience 2017-01-18 TREM2 and immune genetics

    The R47H coding variant of the triggering receptor expressed on myeloid cells-2 (TREM2) increases the risk of Alzheimer's disease (AD) similar to apolipoprotein E4.

  5. Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

    ✓ Peer-reviewed alzhub usefulness score 64 out of 100. JAMA neurology 2015-10-01 Biomarkers

    Among the 128 study participants, the 104 patients with early PD had a different CSF pattern compared with the 13 patients with progressive supranuclear palsy (baseline area under the receiver operating characteristic curve, 0.87; P < .0001) and the 30 control participants (baseline area under the receiver operating characteristic curve, 0.69; P = .0021).

  6. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Journal of the neurological sciences 2011-02-02 Tau biomarkers

    We measured the levels of some biological metals: copper (Cu), iron (Fe), magnesium (Mg), manganese (Mn), and zinc (Zn) in the cerebrospinal fluid (CSF) in patients with neurodegenerative diseases (52 patients with amyotrophic lateral sclerosis (ALS)), 21 patients with Alzheimer's disease (AD), and 20 patients with Parkinson's disease (PD) by inductively coupled plasma mass spectrometry (ICP-MS).

All topic tags with their study counts